End­points hon­ors 20 women lead­ers; Ver­tex teams up with neigh­bor; Pfiz­er ri­val im­press­es; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Our web­site will be buzzing this week­end with live #ASH22 cov­er­age from Kyle LaHu­cik and Paul Schloess­er, so be sure to check the web­site from time to time. They are al­so host­ing a pan­el of ex­perts to dis­cuss key take­aways from the con­fer­ence on Mon­day — you can sign up at no cost here. An­oth­er house­keep­ing note: I’m tak­ing next week off, but you are in good hands with my col­league Lei Lei Wu tak­ing over for the End­points Week­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.